Dr. Anit Singh is a scientific entrepreneur with exceptional medicinal acumen, spirit and a passion to discover, and above all, a commitment to serve the people. He brings on board his vast and varied experiences in successfully completing global clinical trials for pharmaceutical giants like Biogen Idec, Merck, Janssen J&J, Victhom Human Bionics, Wyeth, Mylan, Bharat Biotech and Panacea Biotech among others. In his roles with these organizations he has been instrumental in defining unmet medical need, clinical trials strategy, target indication analysis of market including competition, regulatory strategy, project plan and drug development timeline. He was part of team during successful clearance of audits and inspection by sponsors and regulatory bodies such as FDA, EMEA, WHO, CSIR, CDSCO (DCGI), KFDA, ANVISA and Therapeutic Goods Administration. Dr. Anit has participated in more than 200 trials across the world and has more than 50 publications and abstracts to his candidature. He studied at All India Institute of Medical Sciences, New Delhi and Cleveland Clinic, USA and worked with various agencies like WHO, ICMR, DBT, CSIR and Bill & Melinda Gates Foundation.

Dr. Anit founded Clinical Research Network India, a nationwide consortium of experienced clinicians, expert researchers and clinical research sites that aims to provide expertise and infrastructure support to high level clinical research and accelerate development of life-saving drugs and devices. The Network committed to serve national and international pharma, biotech, medical device, diagnostic, food-nutraceutical, cosmetic industries and contract research organizations. He is instrumental in shaping and leading India’s clinical research industry through International collaboration with various academic and public health associations. His capabilities in instituting strategic alliances among industries have earned distinguished him in the Clinical Trial Industry. He is responsible for overseeing the region’s business operations of the company, new alliances and is focused on stable growth, client satisfaction and long-term relationships.

As a corporate social responsibility, the network dreamed to develop affordable translational health research system for emerging world and touching the lives of millions of people.